The influence of complicating diseases upon leukemia, Am J Med Sci, vol.127, pp.563-92, 1904. ,
History of oncolytic viruses: genesis to genetic engineering, Mol Ther, vol.15, pp.651-660 ,
Natural and genetically engineered viral agents for oncolysis and gene therapy of human cancers, Arch Immunol Ther Exp, 2008. ,
Treatment of human cancer with mumps virus, Cancer, vol.34, pp.1907-1935, 1974. ,
Targeted inflammation during oncolytic virus therapy severely compromises tumor blood flow, Mol Ther, vol.15, pp.1686-93, 2007. ,
Innate immunity, tumor microenvironment and oncolytic virus therapy: friends or foes?, Curr Opin Mol Ther, vol.10, pp.32-39, 2008. ,
Cancer selective adenoviruses, Mol Aspects Med, vol.28, pp.42-58, 2007. ,
Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus, Nat Med, vol.6, pp.821-826, 2000. ,
VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents, Cancer Cell, vol.4, pp.263-75, 2003. ,
In vitro and in vivo kinetics of recombinant vaccinia virus cancer-gene therapy, Surgery, vol.116, pp.183-191, 1994. ,
Systemic administration of a recombinant vaccinia virus expressing the cytosine deaminase gene and subsequent treatment with 5-fluorocytosine leads to tumor-specific gene expression and prolongation of survival in mice, Cancer Res, vol.59, pp.3396-403, 1999. ,
Identification of genetically modified Maraba virus as an oncolytic rhabdovirus, Mol Ther, vol.18, pp.40-49, 2010. ,
Rational strain selection and engineering creates a broad-spectrum, systemically effective oncolytic poxvirus, JX-963, J Clin Invest, vol.117, pp.3350-3358, 2007. ,
Potent systemic therapy of multiple myeloma utilizing oncolytic vesicular stomatitis virus coding for interferonbeta, Cancer Gene Ther, vol.19, pp.443-50, 2012. ,
Enhancement of oncolytic properties of recombinant newcastle disease virus through antagonism of cellular innate immune responses, Mol Ther, vol.17, pp.697-706, 2009. ,
Enhancing poxvirus oncolytic effects through increased spread and immune evasion, Cancer Res, vol.68, pp.2071-2076, 2008. ,
Effective gene-viral therapy of leukemia by a new fiber chimeric oncolytic adenovirus expressing TRAIL: in vitro and in vivo evaluation, Mol Cancer Ther, vol.8, pp.1387-97, 2009. ,
Lymphoma chemovirotherapy: CD20-targeted and convertase-armed measles virus can synergize with fludarabine, Cancer Res, vol.67, pp.10939-10986, 2007. ,
Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter, Blood, vol.103, pp.1641-1647, 2004. ,
Systemic therapy of disseminated myeloma in passively immunized mice using measles virus-infected cell carriers, Mol Ther, vol.18, pp.1155-64, 2010. ,
Oncolytic viruses: a step into cancer immunotherapy, Virus Adaptation and Treatment, vol.4, pp.1-21, 2012. ,
Oncolytic and immunostimulatory efficacy of a targeted oncolytic poxvirus expressing human GM-CSF following intravenous administration in a rabbit tumor model, Cancer Gene Ther, vol.17, pp.73-82, 2009. ,
An oncolytic adenovirus expressing granulocyte macrophage colony-stimulating factor shows improved specificity and efficacy for treating human solid tumors, Cancer Gene Ther, vol.16, pp.33-43, 2009. ,
Buy one get one free": armed viruses for the treatment of cancer cells and their microenvironment, Curr Gene Ther, vol.9, pp.341-55, 2009. ,
Oncolytic viruses and histone deacetylase inhibitors-a multi-pronged strategy to target tumor cells, Cytokine Growth Factor Rev, vol.21, pp.153-162, 2010. ,
Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses, Nat Med, vol.5, pp.881-888, 1999. ,
A high-throughput pharmacoviral approach identifies novel oncolytic virus sensitizers, Mol Ther, vol.18, pp.1123-1132, 2010. ,
Identification of the ENT1 antagonists dipyridamole and dilazep as amplifiers of oncolytic herpes simplex virus-1 replication, Cancer Res, vol.70, pp.3890-3895, 2010. ,
Oncolytic virotherapy, Nat Biotechnol, vol.30, pp.658-70, 2012. ,
Intravenous delivery of a multimechanistic cancer-targeted oncolytic poxvirus in humans, Nature, vol.477, pp.99-102, 2011. ,
Le virus de la rougeole -Un futur traitement en cancérologie ?, Med Sci, vol.28, pp.388-94, 2012. ,
Apprivoiser nos ennemis pour en faire des alliés : la « virothérapie » anticancéreuse, Med Sci, vol.28, pp.339-379, 2012. ,
Le virus de la stomatite vésiculaire dans la lutte contre le cancer, Med Sci, vol.29, pp.175-82, 2013. ,
Neoadjuvant treatment of hepatic malignancy: an oncolytic herpes simplex virus expressing IL-12 effectively treats the parent tumor and protects against recurrence-after resection, Cancer Gene Ther, vol.10, pp.215-238, 2003. ,
Effective intravenous therapy of murine pulmonary metastases with an oncolytic herpes virus expressing interleukin 12, Clin Cancer Res, vol.10, pp.251-260, 2004. ,
Enhanced therapeutic efficacy of IL-12, but not GM-CSF, expressing oncolytic herpes simplex virus for transgenic mouse derived prostate cancers, Cancer Gene Ther, vol.13, pp.253-65, 2006. ,
Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors, Proc Natl Acad Sci, vol.97, pp.2208-2221, 2000. ,
Therapeutic and tumor-specific immunity induced by combination of dendritic cells and oncolytic adenovirus expressing IL-12 and 4-1BBL, Mol Ther, vol.18, pp.264-74, 2010. ,
Triple gene-deleted oncolytic herpes simplex virus vector double-armed with interleukin 18 and soluble B7-1 constructed by bacterial artificial chromosome-mediated system, Cancer Res, vol.65, pp.10663-10671, 2005. ,
Potentiating cancer immunotherapy using an oncolytic virus, Mol Ther, vol.184, pp.4269-75, 2010. ,
Oncolytic herpes simplex virus armed with xenogeneic homologue of prostatic acid phosphatase enhances antitumor efficacy in prostate cancer, Gene Ther, vol.17, pp.805-815, 2010. ,
Intelligent design: combination therapy with oncolytic viruses, Mol Ther, vol.18, pp.251-63, 2010. ,
Synergistic interaction between oncolytic viruses augments tumor killing, Mol Ther, vol.18, pp.888-95, 2010. ,